Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
MANKIND

Mankind Pharma Share Price

 

 

Mankind Pharma live price: ₹2267.4. It opened at ₹2,307 vs previous close ₹2,293; intraday high/low: ₹2,316/₹2,261. The 50 & 200 DMA stand at ₹2,122.51/₹2,243.61.

Mankind Pharma Performance

  • Today's Low
  • ₹2,261
  • Today's High
  • ₹2,316
  • 52 Week Low
  • ₹1,910
  • 52 Week High
  • ₹2,717
  • Open Price₹2,307
  • Previous Close₹2,293
  • Volume293,014
  • 50 DMA₹2,122.51
  • 100 DMA₹2,163.59
  • 200 DMA₹2,243.61

Mankind Pharma Chart

Investment Returns

  • Over 1 Month + 12.03%
  • Over 3 Month + 7.58%
  • Over 6 Month -6.78%
  • Over 1 Year -11.34%

Smart Investing Starts Here Start SIP with Mankind Pharma for Steady Growth!

Invest Now

Mankind Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 52.6
  • PEG Ratio
  • -4.1
  • Market Cap Cr
  • 93,605
  • P/B Ratio
  • 6
  • Average True Range
  • 62.97
  • EPS
  • 45.01
  • Dividend Yield
  • 0
  • MACD Signal
  • 13.2
  • RSI
  • 67.86
  • MFI
  • 87.44

Mankind Pharma Financials

Mankind Pharma Technicals

EMA & SMA

Current Price
₹2,267.40
-25.5 (-1.11%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹2,136.82
  • 50 Day
  • ₹2,122.51
  • 100 Day
  • ₹2,163.59
  • 200 Day
  • ₹2,243.61

Resistance and Support

2281.43 Pivot Speed
  • R3 2,356.77
  • R2 2,336.33
  • R1 2,301.87
  • S1 2,246.97
  • S2 2,226.53
  • S3 2,192.07

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Mankind Pharma Ltd. is one of India’s largest pharmaceutical companies, providing a wide range of affordable medicines in areas like antibiotics, cardiovascular, gastrointestinal, and dermatology. It also manufactures over-the-counter (OTC) products, catering to domestic and global markets.

Mankind Pharma Ltd has an operating revenue of Rs. 13,914.08 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 21% is great, ROE of 13% is good. The company has a reasonable debt to equity of 39%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 9% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 51 which is a POOR score indicating inconsistency in earnings, a RS Rating of 54 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Mankind Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-03 Quarterly Results
2025-11-06 Quarterly Results
2025-07-31 Quarterly Results & Interim Dividend
2025-05-21 Audited Results
2025-01-23 Quarterly Results
Date Purpose Remarks
2025-08-08 INTERIM Rs.1.00 per share(100%)Interim Dividend
View Mankind Pharma Dividend History Arrow

Mankind Pharma F&O

Mankind Pharma Shareholding Pattern

72.66%
10.36%
1.14%
10.24%
0%
1.39%
4.21%

Mankind Pharma FAQs

Mankind Pharma share price is ₹2,267 As on 27 April, 2026 | 00:21

The Market Cap of Mankind Pharma is ₹93604.7 Cr As on 27 April, 2026 | 00:21

The P/E ratio of Mankind Pharma is 52.6 As on 27 April, 2026 | 00:21

The PB ratio of Mankind Pharma is 6 As on 27 April, 2026 | 00:21

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23